Nealbarbital
![]() | |
| Clinical data | |
|---|---|
| ATC code | none |
| Identifiers | |
| |
| Synonyms | Nealbarbital, Censedal |
| CAS Number |
561-83-1 |
| PubChem (CID) | 521716 |
| ChemSpider |
455089 |
| UNII |
25ATP958PA |
| ECHA InfoCard | 100.008.386 |
| Chemical and physical data | |
| Formula | C12H18N2O3 |
| Molar mass | 238.28 g/mol |
| 3D model (Jmol) | Interactive image |
| |
| |
| (verify) | |
Nealbarbital (Censedal) is a barbiturate derivative developed by Aktiebolaget Pharmacia in the 1950s.[1] It has sedative and hypnotic effects, and was used for the treatment of insomnia.
References
- ↑ US Patent 2899435
This article is issued from Wikipedia - version of the 4/2/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
